Death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome was reduced (P=0.005) by early pharmacogical or inteventional ablation for fast response-atrial fibrillation in a small German RCT.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Electrophysiology - Arrhythmias
April 9, 2020
Another refreshing change of pace with an interesting pre-translational contibution to the genetics of atrial dysrhythmias.
December 9, 2019
Given the escalating importance of atrial fibrillation for surgeons, this genomics article may be of considerable interest in future.
November 14, 2019
Interesting succinct note on a major issue, noting a possible association between cardiopulmonary bypass and this common complication.
September 22, 2019
Investigators reported, in abstract form, promising results of a single dose of radiotherapy, delivered with electorphysiologic guidance, for managing ventricular tachycardia. Seventy-eight percent of patients had a clinically important reduction in ventricular tachycardia episodes.
August 19, 2019
A standardized perioperative management protocol for pts taking direct oral anticoagulants for atrial fibrillation entailed no bridging with other anticoagulants. It resulted in low and acceptable rates of major bleeding (<2%) and stroke (<1%).
Prevalence of Atrial Fibrillation Before Cardiac Surgery and Factors Associated With Concomitant Ablation
July 11, 2019
An important update on the evolving landscape of surgery for atrial fibrillation.
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the Watchman Left Atrial Appendage Closure Technology
April 9, 2019
Boersma and associates reported the outcomes of left atrial appendage (LAA) closure with the Watchman device in international registry (EWOLUTION), which recruited 1,020 patients from 47 different centers. Mean age was 73.4 years and 49% had a CHA2DS2-VASc score of 5 or higher—indicating a high risk of stroke.
Right Ventricular Pulmonary Coupling as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
January 18, 2019
A good attempt to shed some light into the somewhat challenging concept of heart failure with preserved ejection fraction, on the occasion of a small randomized controlled trial on albuterol.
August 31, 2018
A balanced editorial discussing the relevant RCT from Britain. The esteemed authors are correct to highlight the overall discouraging survival from out-of-hospital cardiac arrest WITHOUT NEUROLOGICAL DEFICIT. What does need to be done to improve a 3% acceptable outcome?